Form 4: Blueprint Medicines Executive Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Christopher K. Murray, Chief Technical Operations Officer of Blueprint Medicines Corp, sold 2,521 shares of common stock to cover tax withholding obligations.
Summary
- On March 7, 2024, Christopher K. Murray, Chief Technical Operations Officer of Blueprint Medicines Corp, sold 2,521 shares of common stock.
- The sale was executed at a price of $90.69 per share.
- The transaction was conducted to cover tax withholding obligations related to the vesting of restricted stock units.
- Following the transaction, Murray directly owns 33,853 shares of Blueprint Medicines Corp.
- Murray has granted limited power of attorney to Tracey McCain, Melissa Masse, Ariel Hurley, and Michael Landsittel to handle SEC filings on his behalf.
Sentiment
Score: 5
Explanation: The document describes a routine stock sale to cover tax obligations, which is neutral in sentiment.
Industry Context
Sales of shares to cover tax obligations are a routine part of executive compensation and are not necessarily indicative of the company's performance or the executive's confidence in the company.
Key Dates
| Date | Description |
|---|---|
| January 31, 2023 | Date of execution for the Limited Power of Attorney. |
| March 7, 2024 | Date of the stock sale transaction. |
| March 11, 2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.